Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Induction Dose of Nalbuphine on Pupillary Response in Strabismus Surgery
ChiCTR2300073147Phase 4Recruiting
- Sponsor
- Second People's Hospital of Yunnan Province
- Start
- Apr 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalbuphine in strabismus (3 arms), sponsored by Second People's Hospital of Yunnan Province. Primary endpoint: Pupil diameter. Started Apr 2023; status: recruiting.
02
Drugs
nalbuphine
03
Conditions
strabismus
Beyond the preview
Go deeper on ChiCTR2300073147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073147.